Comparison of Hyperbaric 0.5% Levobupivacaine and Hyperbaric 0.75% Ropivacaine for Intrathecal Use in Infraumbilical Surgeries: A Randomised Clinical Study UC01-UC05
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Effect of Different Doses of Intrathecal Nalbuphine as Adjuvant to Hyperbaric Bupivacaine on Characteristics of Subarachnoid Block in Pelvic and Lower Limb Orthopaedic Surgeries: A Randomised Clinical Study UC06-UC12
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Efficacy of Intrathecal 0.75% Hyperbaric Ropivacaine versus 0.5% Hyperbaric Bupivacaine for Elective Inguinal and Perineal Surgery: A Randomised Double-blinded Clinical Study UC13-UC17
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Dexmedetomidine versus Dexamethasone as Perineural Adjuvants in Supraclavicular Brachial Plexus Block: An Interventional Study UC18-UC22
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
Efficacy of 5 μg and 10 μg Dexmedetomidine as Adjuvants to 3 mL 0.5% Hyperbaric Bupivacaine in Pelvic and Lower Limb Orthopaedic Surgeries: A Randomised Clinical Study UC23-UC27
[ABSTRACT ] | [FULL TEXT ] | [ PDF ] | [Google Scholar]
All the research studies published were performed in accordance to the Declaration of Helsinki. Written consent was obtained from all the included subjects (or the responsible next kin), where ever applicable. In case reports or any article which includes patients images, permission was sought from the patient (or the responsible next kin) for publication. Whether or not this has been explicitly stated in the manuscript, this was declared by the authors at the time of submission of manuscript to the journal. In a rare event, if the consent could not be obtained due to loss of patient for follow up or death or loss of contact, even after reasonable effort, the editors then decided on case by case basis, weighing on the individual contribution the report will make to advancement of medical literature.